Navigation Links
Frost & Sullivan Applauds EOS Imaging for its Highly Innovative, X-ray-Based Imaging Modality for Orthopedics

MOUNTAIN VIEW, Calif., Nov. 25, 2013 /PRNewswire/ -- Based on its recent analysis of the medical imaging market, Frost & Sullivan recognizes EOS Imaging with the 2013 North America Frost & Sullivan Award for Product Innovation Leadership. The company's flagship product, the EOS, provides high-quality, whole-body images of a sitting or standing patient, using a fraction of the radiation dose required by conventional imaging methods. A unique modality with no direct competition in the market, the EOS is gradually establishing its presence in the orthopedic space, where it is finding application as a valuable diagnostic, as well as a pre- and post-surgical clinical tool.

The EOS system uses simultaneous image acquisition from two connected imaging assemblies, enabling intrinsic 3-D weight-bearing modeling of the bone envelope from just two views. It also captures frontal and lateral views, without stitching, in a single, low-dose imaging episode. Furthermore, the resulting images are true-size with a one-to-one scale, enabling accurate and reproducible measurements, intuitive interpretation and better-informed clinical insight.

The solution can acquire a full-body image of an adult patient in less than 20 seconds, of a pediatric patient in less than 15 seconds, and totals less than four minutes of exam time, even for the most complex procedures, such as spine imaging. These capabilities have resulted in a clinically effective, economically profitable, new imaging service line for providers.

"The fast and efficient workflow designed for the EOS leverages not only high-performance technology components, but also intelligent software and patient ergonomics," said Frost & Sullivan Principal Analyst Nadim Daher. "With a full-fledged, end-to-end clinical solution, including imaging equipment, clinical applications and associated services, the EOS system competes effectively with the gold standards—radiography, computed tomography (CT), and magnetic resonance (MR) imaging. A growing body of clinical research findings continues to establish strong evidence of the benefits of the EOS system with regard to its clinical value, the workflow it proposes, return on investment (ROI) model, and the low dose administered to patients."

Compared to traditional radiography solutions, the competitively priced EOS system offers numerous avenues for revenue growth. The higher number of clinical procedures addressed by the EOS system, involving more clinical subspecialties, further boosts the ROI opportunity for providers, while generating synergies throughout the imaging enterprise.

Entering the U.S. market with a new product and brand name only four years ago, EOS Imaging has admirably and substantially increased its mindshare in the medical imaging community. The market's adoption of the EOS system has continued to gain momentum, with more than 20 installations in the U.S., including some of the most prestigious healthcare institutions. EOS imaging is one of the Deloitte 2013 Technology Fast 50 laureate companies.

"EOS Imaging's growth in the U.S. market is in line with the company's achievements in Europe and numerous early successes and promising near-term prospects in several markets, including Japan, Singapore and China," noted Daher. "This universal acknowledgment of EOS Imaging's technology and product value validates the value the company brings to the fields of radiology and orthopedics, and the broader imaging community."

Each year, Frost & Sullivan presents this award to the company that has developed an innovative element in a product by leverage leading-edge technologies. The award recognizes the value-added features/benefits of the product and the increased ROI it offers customers, which, in turn, increases customer acquisition and overall market penetration potential.

Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.

About EOS Imaging

EOS imaging designs, develops, and markets EOS®, a revolutionary and patented medical imaging system, based on technology that enabled George Charpak to win the Nobel Prize for Physics. The Company is authorized to market the system in 31 countries, including the United States (FDA), Japan, Canada, Australia and the European Union (EU). Backed by an installed base of over 71 sites and more than 400,000 imaging sessions, EOS® benefits from worldwide recognition within the global medical community. As of December 31, 2012 the Group posted 2012 consolidated revenue of €9.42 million and employs 70 people including an R&D team of 25 engineers. The Group is based in Paris and holds three subsidiaries in Cambridge (Massachusetts), in Canada at Montreal and in Germany, and offices in Singapore.

EOS imaging is listed on Compartment C of the NYSE Euronext Paris
ISIN: FR0011191766 – Ticker: EOSI

Next press release: Annual results 2013 on January 22, 2014 (after market)

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

  • The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
  • The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us:   Start the discussion

Join Us:      Join our community

Subscribe:    Newsletter on "the next big thing"

Register:    Gain access to visionary innovation


Mireya Espinoza
P: 210. 247.3870
F: 210.348.1003

Anne Renevot                                                                             
P: +33 (0)1 55 25 61 24 

Financial communication and investors relations  
Sophie Boulila / Pierre Laurent               
P: +33 (0)1 44 71 94 91

The Ruth Group (US)
Press Relations – Melanie Sollid-Penton
P: 646.536.7023

SOURCE Frost & Sullivan
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
2. Frost & Sullivan: High Uptake of New Drug Therapies and Aging Population Expansion Keep the U.S. Retinal Therapeutics Market Buoyant
3. European Thrombosis Therapeutics Market is Experiencing an Urgent Need for Enhanced Products, Says Frost & Sullivan
4. Frost & Sullivan Research Preview: Top 20 Telehealth Markets
5. Heightened Awareness, Coupled with Expanding Patient Pool, Stimulates Sleep Apnea Diagnostics and Sleep Services Market, Says Frost & Sullivan
6. Frost & Sullivan Recognizes Labcyte for its Commitment to Innovation and Addressing Unmet Needs in the Liquid Handling Market
7. MicroRNA Research to Trigger Tremendous Growth in Related Tools Market, Says Frost & Sullivan
8. Frost & Sullivan: Developing Integration Capabilities Presents a Real Opportunity for Vendors in the European CIS Market
9. Frost & Sullivan: Expanding Sample Prep Market Supports Growth Trends in Molecular Diagnostics Markets
10. Electronic Medical Records Progress from an Enterprise-Centric Solution to a Customer-Specific Application, Finds Frost & Sullivan
11. Frost & Sullivan to Host Complimentary Web Conference: Concerns and Solutions for the Anaesthesia Equipment and Associated Peripherals Market
Post Your Comments:
(Date:11/30/2015)... Texas , Nov. 30, 2015  Hanger, Inc. ... amendment and restatement of the terms of its previously ... Solicitation") relating to its $200,000,000 aggregate principal amount 7⅛% ... other things, (i) the consent fees payable pursuant to ... on the Notes and (iii) the expiration date of ...
(Date:11/30/2015)... NAMUR , Belgium , Nov. 30, ... life sciences company focused on developing blood-based diagnostic tests for ... announced the Company will present at the LD Micro Conference, ... Los Angeles, CA. Attending from VolitionRx will ... and Scott Powell , Vice President of Investor Relations. ...
(Date:11/30/2015)... , November 30, 2015 PFE ... at up to 10 G protein-coupled receptor (GPCR) targets ... to research and develop potential new medicines directed at ... multiple therapeutic areas. --> Heptares Therapeutics ("Heptares"), ... and wholly-owned subsidiary of Sosei Group Corporation ("Sosei"; TSE ...
Breaking Medicine Technology:
(Date:11/30/2015)... , ... November 30, 2015 , ... RoamRight, a leading ... with Public Television’s Travel With Kids to promote family vacations around ... family as they explore international destinations and educate families about the people and places ...
(Date:11/30/2015)... ... November 30, 2015 , ... Advocare Orthopedic ... orthopedic care. Led by John Vitolo, M.D., the center offers their patients ... team at Advocare Orthopedic & Sports Medicine is ready to help their patients ...
(Date:11/30/2015)... ... November 30, 2015 , ... International telepathology consultations ... and KingMed Diagnostics researchers. Their review of more than 1,500 ... UPMC pathologists resulted in significantly altered treatment plans for more than half of ...
(Date:11/30/2015)... ... November 30, 2015 , ... The American Society for Clinical Pathology (ASCP) announced ... Day 2015. On Nov. 30, ASCP shared its “Give a minute. Get tested. Find ... and the importance of getting tested for HIV. , ASCP has asked members to ...
(Date:11/30/2015)... ... ... An inventor from Charlottesville, Va., is concerned about the need for peace and ... due to loud noises," she said, "so I decided that there needs to be ... radio waves and microwaves." , The baby BABY MUFF prevents loud noises, radio waves ...
Breaking Medicine News(10 mins):